These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 21487088
41. Movement disorders and brain iron overload in a new subtype of aceruloplasminemia. Melgari JM, Marano M, Quattrocchi CC, Piperno A, Arosio C, Frontali M, Nuovo S, Siotto M, Salomone G, Altavilla R, di Biase L, Scrascia F, Squitti R, Vernieri F. Parkinsonism Relat Disord; 2015 Jun; 21(6):658-60. PubMed ID: 25864092 [No Abstract] [Full Text] [Related]
42. Tetrabenazine for involuntary movement disorders. Kingston D. Med J Aust; 1979 Jun 30; 1(13):628-30. PubMed ID: 158700 [Abstract] [Full Text] [Related]
43. Tetrabenazine treatment in movement disorders. Paleacu D, Giladi N, Moore O, Stern A, Honigman S, Badarny S. Clin Neuropharmacol; 2004 Jun 30; 27(5):230-3. PubMed ID: 15602104 [Abstract] [Full Text] [Related]
45. Valbenazine-induced parkinsonism. Akbar U, Kim DS, Friedman JH. Parkinsonism Relat Disord; 2020 Jan 30; 70():13-14. PubMed ID: 31785443 [No Abstract] [Full Text] [Related]
46. Tetrabenazine. Hayden MR, Leavitt BR, Yasothan U, Kirkpatrick P. Nat Rev Drug Discov; 2009 Jan 30; 8(1):17-8. PubMed ID: 19116624 [No Abstract] [Full Text] [Related]
47. Role of tetrabenazine for Huntington's disease-associated chorea. Poon LH, Kang GA, Lee AJ. Ann Pharmacother; 2010 Jun 30; 44(6):1080-9. PubMed ID: 20442355 [Abstract] [Full Text] [Related]
48. Sensory trick with metoclopramide-associated tardive tremor. Shprecher D. BMJ Case Rep; 2012 Sep 07; 2012():. PubMed ID: 22962383 [Abstract] [Full Text] [Related]
49. Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia. Meyer JM. CNS Spectr; 2016 Dec 07; 21(S1):13-24. PubMed ID: 28044943 [Abstract] [Full Text] [Related]
50. Usefulness of FEES and responsiveness to tetrabenazine in a case of blepharospasm associated with dystonic-tremorous dsyphagia. Suttrup I, Suntrup S, Oelenberg S, Hamacher C, Dziewas R, Warnecke T. Parkinsonism Relat Disord; 2014 Apr 07; 20(4):466-7. PubMed ID: 24495710 [No Abstract] [Full Text] [Related]
51. The suppression of involuntary movements with tetrabenazine. McLellan DL. Scott Med J; 1972 Nov 07; 17(11):367-70. PubMed ID: 4264428 [No Abstract] [Full Text] [Related]
52. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate. Kazamatsuri H, Chien C, Cole JO. Arch Gen Psychiatry; 1972 Jul 07; 27(1):100-3. PubMed ID: 4555826 [No Abstract] [Full Text] [Related]
53. Valbenazine for the treatment of tardive dyskinesia. Müller T. Expert Rev Neurother; 2017 Dec 07; 17(12):1135-1144. PubMed ID: 28971695 [Abstract] [Full Text] [Related]
54. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. Clin Neuropharmacol; 2008 Dec 07; 31(3):127-33. PubMed ID: 18520979 [Abstract] [Full Text] [Related]
56. Parkinson's disease and other movement disorders. Chen JJ. Am J Geriatr Pharmacother; 2010 Aug 07; 8(4):293. PubMed ID: 20869619 [No Abstract] [Full Text] [Related]